Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
RA Capital Management is a Boston-based investment firm founded in 2004 by Richard Aldrich (Vertex Pharmaceuticals co-founder) and Peter Kolchinsky. ~$12.6B AUM with ~170 employees. Invests in public and private healthcare/life sciences companies across all stages.
Healthcare and life sciences: drug discovery, oncology, infectious diseases, autoimmune, gene therapies, medical devices. Also Planetary Health Fund ($120M) for critical minerals, energy, manufacturing.
543 companies with 128+ exits via IPO or acquisition. Portfolio includes Vaxcyte, Ascendis Pharma, Cidara Therapeutics. TechAtlas research division maps competitive landscapes.
To approach RA Capital Management, founders should submit their pitch through the firm's dedicated pitch page at racap.com/venture. The firm is open to innovative ideas across various stages and sectors within healthcare and life sciences.
RA Capital Management operates the Raven incubator, which supports biotech startups by providing resources and strategic guidance. Additionally, the firm manages the Planetary Health Fund, a $120 million initiative targeting critical minerals, energy, and manufacturing.
RA Capital Management invests in Seed, Series A, Series B, Series C, Series D, and Growth Equity stages.
Founders can pitch RA Capital Management through their website at racap.com/venture.
The firm focuses on biotech, drug discovery, diagnostics, genomics, synthetic biology, healthcare, digital health, climate, energy, and industrial sectors.
RA Capital Management typically invests between $500K and $75M.
RA Capital Management invests globally, with a strong focus on North America and the United States.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.